目前在红色人体原形症的试验:安慰剂对照是否道德?
Jasmin Barman-Aksözen1, Mattia Andreoletti2, Alessandro Blasimme3
1International Porphyria Patient Network, Hegarstrasse 3, 8032, Zurich, Switzerland.
Orphanet journal of rare diseases
|October 16, 2023
概括
德西米拉贡显示出对Erythropoietic protoporphyria (EPP) 的承诺. 研究人员建议主动对照试验,而不是安慰剂,对于测试EPP治疗更为道德和科学合理.
科学领域:
- 医学研究 医学研究
- 临床试验的设计
- 血液学 血液学 血液学
背景情况:
- 红色人体原型 (EPP) 是一种罕见的遗传性疾病.
- 目前的EPP治疗方法已经存在,但像dersimelagon这样的新选择正在研究中.
- 德西米拉贡 (MT-7117) 是一种针对EPF的新型治疗剂.
研究的目的:
- 评估EPP治疗的安慰剂对照试验的伦理和科学有效性.
- 提出一个替代的临床试验设计来评估德西米拉贡的疗效.
- 在有效的治疗方法可用时,解决使用安慰剂手臂的伦理考虑.
主要方法:
- 在EPP中对安慰剂控制的随机对照试验 (RCT) 的伦理影响的分析.
- 审查现有的EPP治疗选择及其对试验设计的影响.
- 作为更合适的替代方案,提出一个非劣势活性对照试验设计.
主要成果:
- 目前,德西米拉贡的III期试验正在美国和欧洲进行安慰剂控制.
- 在EPP试验中使用安慰剂在伦理上是有问题的,因为现有的治疗方法.
- 积极控制试验提供了一个更科学和道德的方法.
结论:
- 对于测试德西米拉贡和其他EPP疗法,建议进行非劣势活性对照试验.
- 这种设计确保了伦理治疗标准,同时严格评估新的干预措施.
- 优化临床试验方法对于推进EPP护理至关重要.
相关概念视频
01:11Blinding
2.5K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
2.5K
02:07Blind Procedures
10.6K
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which...
10.6K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
133
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
133
01:54The Placebo Effect
6.2K
The placebo effect occurs when people's expectations or beliefs influence or determine their experience in a given situation. In other words, simply expecting something to happen can actually make it happen.
6.2K
01:27Nursing Ethical Principles II
993
Ethical principles are essential in guiding nurses to fulfill their responsibilities, focusing on the quality of nursing care and decision-making. These principles, including autonomy, beneficence, non-maleficence, justice, and fidelity, shape the ethical framework within healthcare settings.
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's...
993
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
192
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
192